Copyright
©The Author(s) 2022.
World J Gastroenterol. Feb 28, 2022; 28(8): 840-852
Published online Feb 28, 2022. doi: 10.3748/wjg.v28.i8.840
Published online Feb 28, 2022. doi: 10.3748/wjg.v28.i8.840
Table 2 Clinical outcomes and adverse events of early gastric cancer resection according to treatment modality
Variables | ESD (n =119) | Surgery (n = 119) | P value |
Median hospital stay, d (IQR) | 4.0 (4.0-5.0) | 9.0 (8.0-9.0) | < 0.001 |
ICU admission, n (%) | 1 (0.8) | 0 (0.0) | - |
30-d readmission, n (%) | 3 (2.5)1 | 2 (1.7)2 | - |
Operation-related death, n (%) | 1 (0.8) | 0 (0.0) | - |
Complication, n (%) | 14 (11.8) | 7 (5.9) | 0.110 |
Bleeding (early/late) | 8/0 | 0/0 | |
Perforation (early/late) | 5/0 | N/A | |
Pneumonia (early/late) | 1/0 | 0/0 | |
Anastomosis site leakage (early/late) | N/A | 1/0 | |
Adhesion or bowel obstruction (early/late) | 0/0 | 1/2 | |
Hernia (early/late) | N/A | 1/2 |
- Citation: Lee GH, Lee E, Park B, Roh J, Lim SG, Shin SJ, Lee KM, Noh CK. Long-term outcomes of endoscopic submucosal dissection and surgery for undifferentiated intramucosal gastric cancer regardless of size. World J Gastroenterol 2022; 28(8): 840-852
- URL: https://www.wjgnet.com/1007-9327/full/v28/i8/840.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i8.840